Skip to content

FP7H2020HORIZON

Fondazione Per L'Istituto di Ricerca in Biomedicina

Country
CHSwitzerland
Defence projects
0
Projects, all programmes
23
As coordinator
10
EU contribution (CORDIS)
EUR 19,628,035
Active
2008 to 2022

Projects

23 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
BRCA INSIGHTSUnderstanding the functions of the BRCA protein complexes in DNA break repair and in replication stressH20202022CoordinatorEUR 1,868,153
ISIDOReIntegrated Services for Infectious Disease Outbreak ResearchHORIZON2022ParticipantEUR 85,338
ATACAntibody therapy against coronavirus (COVID-19)H20202020ParticipantEUR 3,923,145
TIL-FITIncreasing the fitness of tumor-infiltrating T cells for cellular immunotherapyH20202019CoordinatorEUR 1,406,250
TANTUMorNEUVACCINENeutrophil subtypes: distinct cellular targets for therapeutic interventionH20202017CoordinatorEUR 265,840
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 182,700
ZIKAllianceA global alliance for Zika virus control and preventionH20202016ParticipantEUR 0
EHVAEuropean HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidatesH20202016ParticipantEUR 0
HRMECHNucleases in homologous recombination: from basic principles to genome editingH20202016CoordinatorEUR 1,999,014
BROADimmuneStructural, genetic and functional analyses of broadly neutralizing antibodies against human pathogensH20202015CoordinatorEUR 1,867,500
PREDICTDissecting the human T cell response to pathogens, allergens, and self-antigensFP72013CoordinatorEUR 2,495,200
IRINVACIMMUNE RESPONSES TO INFLUENZA VACCINEFP72013CoordinatorEUR 100,000
ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the riskFP72012ParticipantEUR 729,599
TIMERTargetIng novel MEchanisms of Resolution in inflammationFP72012ParticipantEUR 363,600
LINFOEPABCD4 T AND B LYMPHOCYTES IN HEPATITIS B PATIENTS: ROLE IN ACUTE AND CHRONIC INFECTIONFP72012CoordinatorEUR 248,451
ADITECAdvanced Immunization TechnologiesFP72011ParticipantEUR 520,610
IDAMSInternational Research Consortium on Dengue Risk Assessment, Management, and SurveillanceFP72011ParticipantEUR 289,920
RADARRationally Designed Aquatic Receptors integrated in label-free biosensor platforms for remote surveillance of toxins and pollutantsFP72011ParticipantEUR 284,387
IMMUNEXPLORENew approaches to analyze and exploit the human B and T cell response against virusesFP72010CoordinatorEUR 1,979,200
NEWTBVACDiscovery and preclinical development of new generation tuberculosis vaccinesFP72010ParticipantEUR 141,948

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.